Department of Neurology, Toulouse University Hospital, Toulouse, France.
Toulouse NeuroImaging Center, Université de Toulouse, Inserm UMR1214, UPS, Toulouse, France.
J Alzheimers Dis. 2020;73(4):1607-1614. doi: 10.3233/JAD-190625.
Sporadic cerebral amyloid angiopathy shows progressive amyloid-β deposition in the wall of small arterioles and capillaries of the leptomeninges and cerebral cortex.
To investigate whether amyloid load and distribution, assessed by florbetapir positron emission tomography (PET), differs between patients with probable CAA-related intracerebral hemorrhage (CAA-ICH) and mild cognitive impairment due to Alzheimer's disease (MCI-AD).
We assessed [18F]florbetapir uptake in 15 patients with probable CAA-ICH and 20 patients with MCI-AD patients. Global and regional florbetapir retention were assessed using standard uptake values ratio (SUVr) in region-based and voxel-wise approaches. Visual reading of florbetapir scans was performed for all participants. Group comparisons were performed using univariate and multivariate analysis.
Global florbetapir retention was lower in patients with CAA-ICH than MCI-AD (median SUVr, 1.33 [1.21-1.41] versus 1.44 [1.35-1.66]; p = 0.032). In the region-based analysis, regional florbetapir distribution was similar between the two groups. There was a trend for an increased occipital/global ratio in CAA-ICH patients compared to MCI-AD (p = 0.060). In the voxel-wise approach, two clusters, one in parietal regions and the other in temporal regions, had higher uptake in MCI-AD relative to CAA patients.
Patients with CAA-ICH had a lower global florbetapir PET burden than patients with MCI-AD. Relative florbetapir retention in the posterior regions tended to be higher in CAA patients in region-based analysis but was not statistically different between groups. Investigation on differences in amyloid deposits distribution between groups required a fine-grained voxel-wise analysis. In future studies, selective amyloid tracers are needed to differentiate vascular from parenchymal amyloid.
散发性脑淀粉样血管病(Cerebral Amyloid Angiopathy,CAA)在软脑膜和大脑皮层的小动静脉壁及毛细血管中呈现出渐进性的β淀粉样蛋白沉积。
研究通过氟比苯正电子发射断层扫描(florbetapir positron emission tomography,PET)评估的淀粉样蛋白负荷和分布是否在可能与 CAA 相关的脑出血(CAA-related intracerebral hemorrhage,CAA-ICH)患者和阿尔茨海默病相关的轻度认知障碍(mild cognitive impairment due to Alzheimer's disease,MCI-AD)患者之间存在差异。
我们评估了 15 名可能患有 CAA-ICH 的患者和 20 名患有 MCI-AD 的患者的[18F]florbetapir 摄取情况。使用基于区域和体素的标准摄取值比(standard uptake values ratio,SUVr)评估了全局和区域 florbetapir 保留情况。对所有参与者进行 florbetapir 扫描的视觉阅读。使用单变量和多变量分析进行组间比较。
与 MCI-AD 患者相比,CAA-ICH 患者的全局 florbetapir 保留较低(中位数 SUVr,1.33 [1.21-1.41] 比 1.44 [1.35-1.66];p=0.032)。在基于区域的分析中,两组之间的 florbetapir 分布相似。与 MCI-AD 患者相比,CAA-ICH 患者的枕部/全局比值有增加的趋势(p=0.060)。在体素分析中,两个聚类,一个在顶叶区域,另一个在颞叶区域,在 MCI-AD 患者中相对于 CAA 患者具有更高的摄取。
与 MCI-AD 患者相比,CAA-ICH 患者的全局 florbetapir PET 负担较低。在基于区域的分析中,CAA 患者的后部区域的相对 florbetapir 保留倾向于较高,但两组之间无统计学差异。要研究两组之间淀粉样蛋白沉积分布的差异,需要进行更精细的体素分析。在未来的研究中,需要使用选择性的淀粉样蛋白示踪剂来区分血管性和实质淀粉样蛋白。